CXCR4 and cancer: Li and Oupicky, investigated biodegradable polymeric plerixafor (PAMD) and found that biodegradable PAMD significantly inhibited cancer invasion and metastasis in vivo, suggesting potential as an optimized CXCR4-targeting strategy (Li and Oupický, 2014; Guo et al., 2025).